Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04639765 · ClinicalTrials.gov registry record · NA
Responses to Information on Treatments for Depression
A NA study, sponsored by Ohio State University.
- Completed
- Registry status
- NA
- Development phase
- 300
- Enrollment target
NCT04639765: Completed NA study, sponsored by Ohio State University.
NCT04639765 is a NA study that has completed, run by Ohio State University. The registered enrollment target is 300 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04639765, a NA study, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- NA
- Development phase
- 300 participants
- Enrollment target
Study Summary
The purpose of this study is to determine the impact of different messages about depression treatments.
Primary Outcome
The CEQ is a validated, commonly used measure assessing views of the credibility and expectations for benefit from a treatment.
Interventions
- OTHER CBT without Personalization
- OTHER CBT with Personalization
- OTHER ADM without Personalization
- OTHER ADM with Personalization
- OTHER Combined Treatment without Personalization
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 300 participants |
| Start Date | 2020-10-28 |
| Est. Completion | 2020-12-30 |
| Phase | NA |
What the finished NCT04639765 record still lists
NCT04639765 is an interventional study that assigns participants to a tested intervention. The registered 300 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (79% lower).
The record links to 0 conditions, and to 5 interventions - of which CBT without Personalization is the first listed.
NCT04639765 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT04639765 about?
NCT04639765 is a clinical study titled "Responses to Information on Treatments for Depression". The purpose of this study is to determine the impact of different messages about depression treatments.
What is the current status of trial NCT04639765?
This trial is currently completed. It is a NA study. The enrollment target is 300 participants. The study started on 2020-10-28. Estimated completion is 2020-12-30.
What interventions are being tested in trial NCT04639765?
The interventions under investigation include: CBT without Personalization (OTHER), CBT with Personalization (OTHER), ADM without Personalization (OTHER), ADM with Personalization (OTHER), Combined Treatment without Personalization (OTHER).
Who is sponsoring clinical trial NCT04639765?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT04639765's enrollment target sits among peer trials
300 330th of 2000 higher than 1,630 of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00353483 · 300 participants
Effect of Neoadjuvant or Adjuvant Systemic Therapy on Breast Cancers, Bone Marrow Cancer Cells, and Circulating Cancer Cells
- NCT00588185 · 300 participants · NA
[18F]-Fluoro-2-Deoxy-D-Glucose and -[18F] Dihydro-Testosterone Pet Imaging in Patients With Progressive Prostate Cancer
- NCT00682032 · 300 participants · NA
The Effect of Beta-glucan in Non-Small Cell Lung Cancer
- NCT00870064 · 300 participants · NA
The Treatment of Type I Open Fractures in Pediatrics
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI